Cytomorphological features of ALK‐positive lung adenocarcinomas: Psammoma bodies and signet ring cells

Publisher： John Wiley & Sons Inc

E-ISSN： 1934-6638|123|3|162-170

ISSN： 1934-662x

Source： CANCER CYTOPATHOLOGY, Vol.123, Iss.3, 2015-03, pp. : 162-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nivolumab Therapy for Synchronous ALK-Positive Lung Cancer and Gastric Cancer

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-04 ,pp. : 361-367

Karger

Access to resources Recommend Favorite

Phenotypic variation of an ALK‐positive large‐cell neuroendocrine lung carcinoma with carcinoid morphology during treatment with ALK inhibitors

By  

HISTOPATHOLOGY, Vol. 72, Iss. 4, 2018-03 ,pp. : 707-710

John Wiley & Sons Inc

Access to resources Recommend Favorite

ALK‐positive non–small cell lung cancer: Mechanisms of resistance and emerging treatment options

By  

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2392-2402

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug‐induced reduction in estimated glomerular filtration rate in patients with ALK‐positive non‐small cell lung cancer treated with the ALK inhibitor crizotinib

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 664-674

John Wiley & Sons Inc

Access to resources Recommend Favorite

Update on the potential significance of psammoma bodies in lung adenocarcinoma from a modern perspective

By  

HISTOPATHOLOGY, Vol. 72, Iss. 4, 2018-03 ,pp. : 609-618

John Wiley & Sons Inc

Access to resources Recommend Favorite